4//SEC Filing
Wilfong Diane E. 4
Accession 0001127602-25-017339
CIK 0000882095other
Filed
Jun 10, 8:00 PM ET
Accepted
Jun 11, 7:10 PM ET
Size
8.4 KB
Accession
0001127602-25-017339
Insider Transaction Report
Form 4
Wilfong Diane E
Interim Corp Controller & CAO
Transactions
- Exercise/Conversion
Restricted Stock Unit
2025-06-10−920→ 8,785 total→ Common Stock (920 underlying) - Tax Payment
Common Stock
2025-06-10$110.09/sh−340$37,431→ 45,676 total - Exercise/Conversion
Common Stock
2025-06-10+920→ 46,016 total
Footnotes (2)
- [F1]Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
- [F2]The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
Documents
Issuer
GILEAD SCIENCES, INC.
CIK 0000882095
Entity typeother
Related Parties
1- filerCIK 0001374988
Filing Metadata
- Form type
- 4
- Filed
- Jun 10, 8:00 PM ET
- Accepted
- Jun 11, 7:10 PM ET
- Size
- 8.4 KB